Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer.

Yu JI, Huh SJ, Kim YI, Kim TJ, Park BK.

Radiat Oncol J. 2011 Sep;29(3):214-7. doi: 10.3857/roj.2011.29.3.214. Epub 2011 Sep 30.

2.

Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.

Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E.

J Nucl Med. 2004 Feb;45(2):266-71.

4.

F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case report.

Nguyen NC, Hueser CN, Kaushik A, Farghaly HR, Osman MM.

J Med Case Rep. 2010 Aug 20;4:282. doi: 10.1186/1752-1947-4-282.

5.

18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.

Schwarz JK, Lin LL, Siegel BA, Miller TR, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1502-7. doi: 10.1016/j.ijrobp.2008.03.040. Epub 2008 Jun 4.

PMID:
18538498
6.

FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.

Sakurai H, Suzuki Y, Nonaka T, Ishikawa H, Shioya M, Kiyohara H, Katoh H, Nakayama Y, Hasegawa M, Nakano T.

Gynecol Oncol. 2006 Mar;100(3):601-7. Epub 2005 Oct 28.

PMID:
16257440
7.

Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer.

Cho YB, Chun HK, Kim MJ, Choi JY, Park CM, Kim BT, Lee SJ, Yun SH, Kim HC, Lee WY.

World J Surg. 2009 Dec;33(12):2688-94. doi: 10.1007/s00268-009-0248-3.

PMID:
19823904
8.

18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.

Kunos C, Radivoyevitch T, Abdul-Karim FW, Faulhaber P.

Int J Gynecol Cancer. 2011 Aug;21(6):1117-23. doi: 10.1097/IGC.0b013e31821dc8b5.

PMID:
21792015
9.

Physiological uptake of 18F-fluorodeoxyglucose in uterine endometrium and myometrium: correlation with uterine motility evaluated by cine magnetic resonance imaging.

Kido A, Nakamoto Y, Nishizawa S, Yamamoto A, Fujimoto K, Okada H, Togashi K.

Acta Radiol. 2009 May;50(4):455-61. doi: 10.1080/02841850902839692.

PMID:
19373569
10.

The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.

Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D.

J Nucl Med. 2009 May;50 Suppl 1:64S-73S. doi: 10.2967/jnumed.108.057257. Epub 2009 Apr 20. Review.

11.

The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.

Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ.

Am J Clin Oncol. 2012 Aug;35(4):340-4. doi: 10.1097/COC.0b013e3182118e7d.

PMID:
21422901
12.
13.

[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.

Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, Mönig SP, Metzger R, Schicha H, Schmidt M.

Ann Surg. 2009 Dec;250(6):888-94.

PMID:
19953708
14.

Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.

Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1506-12.

PMID:
15050330
15.

18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer.

Nam H, Huh SJ, Ju SG, Park W, Lee JE, Choi JY, Kim BT, Kim CK, Park BK.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e29-34. doi: 10.1016/j.ijrobp.2012.02.055. Epub 2012 Apr 13.

PMID:
22503526
16.

Case of uterine leiomyoma showing fludeoxyglucose uptake on F-18 fludeoxyglucose positron emission tomography/computed tomography.

Park JH, Han JY, Hyun IY, Lee BI, Moon YS.

J Obstet Gynaecol Res. 2010 Dec;36(6):1261-4. doi: 10.1111/j.1447-0756.2010.01307.x. Epub 2010 Nov 18.

PMID:
21083837
17.

Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.

Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY.

Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):757-63. Epub 2005 Mar 17.

PMID:
15772859
18.

[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.

Petit SF, van Elmpt WJ, Oberije CJ, Vegt E, Dingemans AM, Lambin P, Dekker AL, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):698-705. doi: 10.1016/j.ijrobp.2010.06.016. Epub 2010 Sep 29.

PMID:
20884128
19.

The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, Panzavolta R, Crepaldi G, Rampin L, Facci E, Gava M, Banti E, Marano G.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1461-9. doi: 10.1016/j.ijrobp.2008.10.064. Epub 2009 May 4.

PMID:
19419820
20.

Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.

Bjurberg M, Kjellén E, Ohlsson T, Bendahl PO, Brun E.

Int J Gynecol Cancer. 2009 Dec;19(9):1600-5. doi: 10.1111/IGC.0b013e3181c00359.

PMID:
19955945
Items per page

Supplemental Content

Write to the Help Desk